Treatment-naive patients were randomly assigned ( @:@ ratio ) by an interactive voice-response system with a computer-generated random allocation sequence ( stratified by cirrhosis status ) to receive daclatasvir @ mg once daily plus asunaprevir @ mg twice daily or placebo for @ weeks .